54 Companies to Present at Mass Opportunities Biotechnology Investment Conference on November 3, 2005; Massachusetts Governor Mitt Romney to Deliver Keynote Address; Panel discussions will cover key therapeutic areas, global deal making, IPO trends.CAMBRIDGE, Mass. -- Fifty-four life sciences companies will present at the upcoming MASS Opportunities biotechnology investment conference. The event is expected to attract more than 800 attendees. Massachusetts Massachusetts (măsəch  `sĭts), most populous of the New England states of the NE United States. Governor Mitt Romney  This article or section contains information about one or more candidates in an upcoming or ongoing election.Content may change as the election approaches. will deliver the keynote address keynote address n. An opening address, as at a political convention, that outlines the issues to be considered. Also called keynote speech. Noun 1. . Eight panel discussions and presentations will bring together industry and academic thought leaders on research and development, corporate strategies, policy and regulatory issues, and market trends in the life sciences industry. "The upcoming MassOpps conference will feature a diverse group of companies working at the forefront of life sciences," said MBC (Multimedia Benchmark Committee) A graphics benchmark that provides MPEG-2 and other tests. See GPC. President Thomas Finneran Thomas M. Finneran (b. January 27, 1950[1]), Massachusetts politician, is that state's former Speaker of the Massachusetts House of Representatives, having served in that capacity from April 1996 to September 2004. . "The corporate participants include private and public, late-stage and early-stage companies working across major therapeutic areas. The event will also draw leaders in the fields of law and capital markets. Together, these participants will deliver a compelling mix of perspectives on the issues that will shape the course of the life sciences industry in the years to come." Finneran concluded: "We see strong interest in this year's MassOpps among industry participants, academics, institutional investors Institutional Investor A non-bank person or organization that trades securities in large enough share quantities or dollar amounts that they qualify for preferential treatment and lower commissions. and financial analysts. We continue to encourage people to register for the event." The MASS Opportunities Conference will take place on Thursday, November 3rd at the Hilton Logan Airport Hotel. To register for this conference or for more information, visit http://www.massopps.com, or contact the Massachusetts Biotechnology Council at (617) 577-8198. About the MBC The Massachusetts Biotechnology Council (MBC) is committed to advancing the development of critical new science, technology and medicines that benefit people worldwide. Representing over 450 companies, academic institutions and service organizations involved in biotechnology and healthcare, we continue to create value for our members in the areas of public policy and advocacy, events and conferences and industry development. Other areas include professional development programs, industry news and information, career and educational initiatives, workforce training, and our purchasing consortium, which is responsible for negotiating a broad-based broad-based Of or relating to an index or average that provides a good representation of the overall market. The S&P 500 and NYSE Composite are generally regarded as broad-based stock indexes, while the popular Dow Jones Industrial Average is biased collection of contracts and services on behalf of member companies and provides substantial cost savings for large and small organizations. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion